標(biāo)題: Titlebook: Anticoagulation Management; A Guidebook for Phar Anne Rose Book 2015 Springer International Publishing Switzerland 2015 Ambulatory.Care Tra [打印本頁(yè)] 作者: 烏鴉 時(shí)間: 2025-3-21 17:54
書目名稱Anticoagulation Management影響因子(影響力)
作者: 定點(diǎn) 時(shí)間: 2025-3-21 23:09
Direct Oral Anticoagulantsbe experts in the pharmacology and pharmacokinetics of these medications and have the ability to increase the safe use of DOACs through several avenues. This chapter outlines the role of the pharmacist in the management of DOAC medications.作者: FRAX-tool 時(shí)間: 2025-3-22 00:51 作者: 含沙射影 時(shí)間: 2025-3-22 06:12 作者: Endemic 時(shí)間: 2025-3-22 11:25
Book 2015ents on anticoagulant therapy, the information presented within highlights the growing role of the pharmacist in these contexts. Readers will find useful information on anticoagulant management across all pharmacy practice areas, including the inpatient, ambulatory, emergency services and transition作者: Veneer 時(shí)間: 2025-3-22 13:13
,Durchführungstechnische Gesichtspunkte,narrow therapeutic goal. In the hospital setting, where the patient health status may quickly change, having a pharmacist involved in the management of warfarin is crucial. This chapter will focus on how the pharmacist can be involved in the initiation, management, monitoring, and education of warfarin therapy.作者: babble 時(shí)間: 2025-3-22 20:32
https://doi.org/10.1007/978-3-8349-9848-4be experts in the pharmacology and pharmacokinetics of these medications and have the ability to increase the safe use of DOACs through several avenues. This chapter outlines the role of the pharmacist in the management of DOAC medications.作者: Receive 時(shí)間: 2025-3-22 21:27 作者: 擁護(hù) 時(shí)間: 2025-3-23 02:48 作者: Decrepit 時(shí)間: 2025-3-23 09:35 作者: 嚴(yán)峻考驗(yàn) 時(shí)間: 2025-3-23 11:02
https://doi.org/10.1007/978-3-658-03700-0n inhibitors; however, there is emerging data to suggest the use of fondaparinux or the direct oral anticoagulants can also be used to treat HIT..This chapter will focus on the pharmacist’s role in the diagnosis, laboratory interpretation, selection of treatment options, and overall management of HIT.作者: 注視 時(shí)間: 2025-3-23 15:33
Ambulatory Warfarin Managementement of warfarin in the ambulatory setting is associated with improved outcomes and decreased adverse events. This chapter will focus on describing the role of the pharmacist in outpatient warfarin management and provide examples of warfarin management plans, dosing nomograms, monitoring, documentation, and patient education.作者: COKE 時(shí)間: 2025-3-23 20:11
Prevention of Venous Thromboembolism..This chapter will focus on how the pharmacist can use their clinical skills to assist with identifying high VTE risk patients and selection of the most appropriate strategy to prevent VTE based on individual patient-specific risk factors.作者: 使人煩燥 時(shí)間: 2025-3-24 00:50 作者: curriculum 時(shí)間: 2025-3-24 05:05 作者: 協(xié)議 時(shí)間: 2025-3-24 08:31
Einstellungsgespr?che erfolgreich führeners. This chapter describes the role of the pharmacist in anticoagulation reversal and provides specific examples of pharmacist involvement at each step of the process: patient assessment, selection of therapy, and follow-up monitoring.作者: floodgate 時(shí)間: 2025-3-24 11:33 作者: Cardioversion 時(shí)間: 2025-3-24 15:40 作者: 無(wú)思維能力 時(shí)間: 2025-3-24 23:04
Unfractionated Heparin and Low Molecular Weight Heparinrriers to outpatient use if needed (self-administration techniques, financial burdens, etc). Pharmacists are in the ideal position to address all of these expectations. This chapter outlines the role of the pharmacist in the management of patients on UFH and LMWH.作者: 慢慢流出 時(shí)間: 2025-3-25 00:32
Anticoagulation Reversalers. This chapter describes the role of the pharmacist in anticoagulation reversal and provides specific examples of pharmacist involvement at each step of the process: patient assessment, selection of therapy, and follow-up monitoring.作者: evasive 時(shí)間: 2025-3-25 06:06 作者: Flawless 時(shí)間: 2025-3-25 09:05
Anticoagulation Stewardshipl and central role in the implementation and management of the stewardship program. This chapter will focus on how to develop, implement, and monitor the outcomes of an anticoagulation stewardship program. It will also outline the pharmacist role in these programs.作者: breadth 時(shí)間: 2025-3-25 15:31 作者: 編輯才信任 時(shí)間: 2025-3-25 19:47 作者: Dna262 時(shí)間: 2025-3-25 23:21 作者: bisphosphonate 時(shí)間: 2025-3-26 03:59 作者: atopic 時(shí)間: 2025-3-26 06:54
Anticoagulation Reversale-threatening bleed or need for an emergent procedure. The reversal of heparins and warfarin is well established; however, limited data exist for the reversal of direct oral anticoagulants. Because of the limited evidence for these agents, reversal strategies and procedures vary among institutions. 作者: 空中 時(shí)間: 2025-3-26 09:08
Prevention of Venous Thromboembolismcommon preventable causes of death in hospitalized patients. While most hospitalized patients will have at least one risk factor for developing VTE, not all factors have the same weighted risk associated with causing VTE. VTE risk assessment models were created to help assist providers with identify作者: TRUST 時(shí)間: 2025-3-26 15:01 作者: CYN 時(shí)間: 2025-3-26 17:32 作者: 文件夾 時(shí)間: 2025-3-27 00:02 作者: 不感興趣 時(shí)間: 2025-3-27 04:53 作者: carbohydrate 時(shí)間: 2025-3-27 06:50
Anticoagulation Stewardshipof these programs. The stewardship model may be designed as a holistic approach that incorporates all aspects of the medication use process involving both anticoagulants and clotting factor concentrates or alternatively may focus on a particular care setting or aspect of anticoagulation that targets作者: 新陳代謝 時(shí)間: 2025-3-27 12:58 作者: 集聚成團(tuán) 時(shí)間: 2025-3-27 14:52
Peri-procedural Anticoagulationsed at a local healthcare level. As a consequence, high-grade evidence is lacking for the dosing and monitoring of anticoagulants in the peri-procedural setting. Multi-disciplinary input is essential to optimise patient care, and pharmacists are in the ideal position to lead effective anticoagulant 作者: Mobile 時(shí)間: 2025-3-27 20:35
Employer Branding: Innen beginnensed at a local healthcare level. As a consequence, high-grade evidence is lacking for the dosing and monitoring of anticoagulants in the peri-procedural setting. Multi-disciplinary input is essential to optimise patient care, and pharmacists are in the ideal position to lead effective anticoagulant 作者: chemoprevention 時(shí)間: 2025-3-28 01:49
on therapy is provided in the second major section, including descriptions of the role of pharmacists in assessing venous thromboembolism risk, ensuring patients receive appropriate prophylactic therapy, and mo978-3-319-37233-4978-3-319-22602-6作者: –LOUS 時(shí)間: 2025-3-28 04:18 作者: GRILL 時(shí)間: 2025-3-28 06:51
978-3-319-37233-4Springer International Publishing Switzerland 2015作者: euphoria 時(shí)間: 2025-3-28 12:45 作者: 填滿 時(shí)間: 2025-3-28 15:40
,Spezielle Fragen/überprüfung der Antworten,of indications including, atrial fibrillation, mechanical heart valve replacement, venous thromboembolism, etc. A major challenge to the management of warfarin is the narrow therapeutic window needed for both the safety and efficacy of the drug. When below the therapeutic range, an increased risk of作者: 恃強(qiáng)凌弱的人 時(shí)間: 2025-3-28 19:41 作者: 裂口 時(shí)間: 2025-3-29 01:45
https://doi.org/10.1007/978-3-8349-9848-4. These agents may be used for either treatment or prophylaxis of systemic embolism and have been compared to vitamin K antagonist (e.g., warfarin) for many of the same indications. DOACs bring several advantages over traditional therapies but also reveal a new set of challenges. Pharmacists should 作者: 沙發(fā) 時(shí)間: 2025-3-29 05:28 作者: fiction 時(shí)間: 2025-3-29 09:54
https://doi.org/10.1007/978-3-658-10601-0common preventable causes of death in hospitalized patients. While most hospitalized patients will have at least one risk factor for developing VTE, not all factors have the same weighted risk associated with causing VTE. VTE risk assessment models were created to help assist providers with identify作者: 結(jié)合 時(shí)間: 2025-3-29 12:07
Transparenz: Ehrlich w?hrt am l?ngstens the introduction of novel pharmacologic treatments, as well as, increased use of catheter-directed thrombolysis, systemic intravenous thrombolysis, and surgical embolectomy interventions have been utilized either instead of or in addition to traditional VTE treatment with the hopes to improve outc作者: Ligament 時(shí)間: 2025-3-29 17:48
Employer Branding: Innen beginnenuire careful planning to ensure they receive optimal dosing and monitoring of medications, to avoid potential harm. The use of anticoagulants requires a delicate balance between the risks of procedural bleeding and the risks of thrombosis due to suspension of therapy, particularly in high-risk patie作者: demote 時(shí)間: 2025-3-29 21:22
https://doi.org/10.1007/978-3-658-03700-0ar sooner in patients who were previously exposed to heparin within the past 100 days. Typical presentation includes a decline in platelet count by 50 % from baseline. The diagnosis of HIT can be complex and should utilize both clinical presentation and laboratory confirmation. The treatment of HIT
